新三板公(gong)(gong)(gong)司(si)天(tian)松醫療發(fa)布公(gong)(gong)(gong)告稱，公(gong)(gong)(gong)司(si)于(yu)2021年(nian)6月18日向(xiang)浙江證監局(ju)提交了向(xiang)不(bu)特(te)定合格投資者公(gong)(gong)(gong)開發(fa)行股票(piao)并在(zai)精選層掛(gua)牌輔(fu)導備案材料，輔(fu)導機構為財通證券股份有限(xian)公(gong)(gong)(gong)司(si)。公(gong)(gong)(gong)司(si)已與財通證券股份有限(xian)公(gong)(gong)(gong)司(si)簽署(shu)相關輔(fu)導協議。

　　公(gong)(gong)告(gao)稱，公(gong)(gong)司(si) 2019 年(nian)度、2020 年(nian)度已披露的財務(wu)數據(ju)符合精選層(ceng)財務(wu)標準一(yi)。

　　資料顯示(shi)，公司主要(yao)生產銷(xiao)售外(wai)科(ke)(ke)內窺鏡微(wei)創(chuang)(chuang)(chuang)醫(yi)(yi)療(liao)(liao)器(qi)械(xie)、婦科(ke)(ke)內窺鏡微(wei)創(chuang)(chuang)(chuang)醫(yi)(yi)療(liao)(liao)器(qi)械(xie)，其中(zhong)外(wai)科(ke)(ke)內窺鏡微(wei)創(chuang)(chuang)(chuang)醫(yi)(yi)療(liao)(liao)器(qi)械(xie)主要(yao)包(bao)括腹部外(wai)科(ke)(ke)微(wei)創(chuang)(chuang)(chuang)醫(yi)(yi)療(liao)(liao)器(qi)械(xie)、骨外(wai)科(ke)(ke)微(wei)創(chuang)(chuang)(chuang)醫(yi)(yi)療(liao)(liao)器(qi)械(xie)、顯微(wei)外(wai)科(ke)(ke)微(wei)創(chuang)(chuang)(chuang)醫(yi)(yi)療(liao)(liao)器(qi)械(xie)等(deng)。